Euroopa Liit - eesti - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastilised ained - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.

Euroopa Liit - eesti - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic kasvajad, kastreerimine-vastupidavad - antineoplastilised ained - treatment of adult patients with prostate cancer.

Eesti - eesti - Ravimiamet

janssen pharmaceutica - nirapariib+abirateroon - tablett - 100mg+500mg 60tk

Eesti - eesti - Ravimiamet

janssen pharmaceutica - nirapariib+abirateroon - tablett - 50mg+500mg 60tk

Eesti - eesti - Ravimiamet

tesaro bio netherlands b.v. - nirapariib - kõvakapsel - 100mg 56tk

Eesti - eesti - Ravimiamet

millmount healthcare limited - nirapariib - õhukese polümeerikattega tablett - 100mg 56tk